High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
NCT ID: NCT06381076 Phase: PHASE3 Status: COMPLETED Enrollment: 35 Completion: 2025-05-13
Conditions
Chronic Kidney Disease 5D
Interventions
Liposomal curcumin, Food colorant
Summary
A 12-week double-blind randomized control trial will be conducted among adults on hemodialysis (n=15) to determine the impact of liposomal curcumin in a high-protein product on inflammation markers and oxidative stress. Participants will be randomized via a computer-generator into either the control or intervention group. Participants in each group will be given a total of 38 g of a high protein product with or without 7 mls of liposomal curcumin for a total of 8 weeks. At baseline, weeks 8 and 12, participants will have blood sampled and complete a 3-day 24-hour recalls (2 non-dialysis days and 1 dialysis day) and a quality of life survey.
Primary Outcome
high-sensitivity C-reactive protein